For: | Agolli L, Maurizi Enrici R, Osti MF. Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients? World J Gastroenterol 2016; 22(3): 1131-1138 [PMID: 26811652 DOI: 10.3748/wjg.v22.i3.1131] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i3/1131.htm |
Number | Citing Articles |
1 |
Ali Guner, Sang Yong Kim, Jae Eun Yu, In Kyung Min, Yun Ho Roh, Chulkyu Roh, Won Jun Seo, Minah Cho, Seohee Choi, Yoon Young Choi, Taeil Son, Jae-Ho Cheong, Woo Jin Hyung, Sung Hoon Noh, Hyoung-Il Kim. Parameters for Predicting Surgical Outcomes for Gastric Cancer Patients: Simple Is Better Than Complex. Annals of Surgical Oncology 2018; 25(11): 3239 doi: 10.1245/s10434-018-6684-2
|
2 |
Yuhree Kim, Malcolm H. Squires, George A. Poultsides, Ryan C. Fields, Sharon M. Weber, Konstantinos I. Votanopoulos, David A. Kooby, David J. Worhunsky, Linda X. Jin, William G. Hawkins, Alexandra W. Acher, Clifford S. Cho, Neil Saunders, Edward A. Levine, Carl R. Schmidt, Shishir K. Maithel, Timothy M. Pawlik. Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy. Surgery 2017; 162(2): 285 doi: 10.1016/j.surg.2017.03.023
|
3 |
Hee-Sung Ahn, Tae Sung Sohn, Mi Jeong Kim, Byoung Kyu Cho, Su Mi Kim, Seung Tae Kim, Eugene C. Yi, Cheolju Lee. SEPROGADIC – serum protein-based gastric cancer prediction model for prognosis and selection of proper adjuvant therapy. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-34858-x
|
4 |
Linda Agolli, Luca Nicosia. Between evidence and new perspectives on the current state of the multimodal approach to gastric cancer: Is there still a role for radiation therapy?. World Journal of Gastrointestinal Oncology 2018; 10(9): 271-281 doi: 10.4251/wjgo.v10.i9.271
|
5 |
Mohsen Akhondi-Meybodi, Marzieh Ghane, Sara Akhondi-Meybodi, Golnaz Dashti. Five-year Survival Rate for Gastric Cancer in Yazd Province, Central Iran, from 2001 to 2008. Middle East Journal of Digestive Diseases 2017; 9(1): 39 doi: 10.15171/mejdd.2016.50
|